Shelton Capital Management Bristol Myers Squibb CO Transaction History

Shelton Capital Management

  • $3.85 Billion
  • Q3 2024

A detailed history of Shelton Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Shelton Capital Management holds 110,083 shares of BMY stock, worth $6.36 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
110,083
Previous 119,154 7.61%
Holding current value
$6.36 Million
Previous $4.95 Million 15.12%
% of portfolio
0.15%
Previous 0.14%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$39.66 - $51.75 $359,755 - $469,424
-9,071 Reduced 7.61%
110,083 $5.7 Million
Q2 2024

Aug 13, 2024
SELL
$40.25 - $52.99 $52,365 - $68,939
-1,301 Reduced 1.08%
119,154 $4.95 Million
Q1 2024

May 15, 2024
SELL
$47.98 - $54.4 $268,592 - $304,531
-5,598 Reduced 4.44%
120,455 $6.53 Million
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $424,345 - $506,361
-8,753 Reduced 6.49%
126,053 $6.47 Million
Q3 2023

Nov 14, 2023
SELL
$57.89 - $64.73 $127,242 - $142,276
-2,198 Reduced 1.6%
134,806 $7.82 Million
Q2 2023

Aug 10, 2023
SELL
$63.71 - $70.74 $2.09 Million - $2.32 Million
-32,798 Reduced 19.32%
137,004 $8.76 Million
Q1 2023

May 11, 2023
BUY
$65.71 - $74.53 $8.81 Million - $9.99 Million
134,002 Added 374.31%
169,802 $11.8 Million
Q4 2022

Feb 13, 2023
SELL
$68.48 - $81.09 $5.43 Million - $6.43 Million
-79,258 Reduced 68.89%
35,800 $2.58 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $2,423 - $1.43 Million
18,640 Added 19.33%
115,058 $8.18 Million
Q2 2022

Aug 11, 2022
SELL
$72.62 - $79.98 $406,889 - $448,127
-5,603 Reduced 5.49%
96,418 $7.42 Million
Q1 2022

May 12, 2022
BUY
$61.48 - $73.72 $2.6 Million - $3.11 Million
42,247 Added 70.68%
102,021 $7.45 Million
Q4 2021

Feb 11, 2022
SELL
$53.63 - $62.52 $2.05 Million - $2.39 Million
-38,200 Reduced 38.99%
59,774 $3.73 Million
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $2.39 Million - $2.8 Million
40,380 Added 70.11%
97,974 $5.8 Million
Q2 2021

Aug 12, 2021
BUY
$61.91 - $67.42 $1.98 Million - $2.16 Million
32,000 Added 125.03%
57,594 $3.85 Million
Q1 2021

May 14, 2021
SELL
$59.34 - $66.74 $41,122 - $46,250
-693 Reduced 2.64%
25,594 $1.62 Million
Q4 2020

Feb 16, 2021
SELL
$57.74 - $65.43 $9.05 Million - $10.3 Million
-156,730 Reduced 85.64%
26,287 $1.63 Million
Q3 2020

Nov 09, 2020
BUY
$57.43 - $63.64 $9 Million - $9.97 Million
156,692 Added 595.22%
183,017 $11 Million
Q2 2020

Aug 12, 2020
BUY
$54.82 - $64.09 $25,655 - $29,994
468 Added 1.81%
26,325 $1.55 Million
Q4 2019

Feb 11, 2020
SELL
$49.21 - $64.19 $148,023 - $193,083
-3,008 Reduced 10.42%
25,857 $1.66 Million
Q3 2019

Nov 13, 2019
SELL
$42.77 - $50.71 $8,554 - $10,142
-200 Reduced 0.69%
28,865 $1.46 Million
Q2 2019

Aug 14, 2019
BUY
$44.62 - $49.34 $1.23 Million - $1.36 Million
27,626 Added 1919.81%
29,065 $1.32 Million
Q1 2019

May 10, 2019
SELL
$45.12 - $53.8 $1.32 Million - $1.58 Million
-29,326 Reduced 95.32%
1,439 $30.2 Million
Q4 2018

Jan 31, 2019
SELL
$48.76 - $63.23 $141,404 - $183,367
-2,900 Reduced 8.61%
30,765 $1.6 Million
Q3 2018

Nov 14, 2018
BUY
$55.19 - $62.25 $27,043 - $30,502
490 Added 1.48%
33,665 $2.09 Million
Q2 2018

Aug 10, 2018
BUY
$50.53 - $62.98 $62,151 - $77,465
1,230 Added 3.85%
33,175 $1.84 Million
Q1 2018

May 15, 2018
SELL
$59.92 - $68.98 $29,960 - $34,490
-500 Reduced 1.54%
31,945 $2.02 Million
Q3 2017

Nov 14, 2017
SELL
$55.23 - $63.74 $22,092 - $25,496
-400 Reduced 1.22%
32,445 $2.07 Million
Q2 2017

Aug 14, 2017
BUY
N/A
900 Added 2.82%
32,845 $1.83 Million
Q1 2017

Nov 28, 2017
SELL
N/A
-400 Reduced 1.24%
31,945 $1.74 Million
Q4 2016

Nov 29, 2017
SELL
N/A
-11,250 Reduced 25.81%
32,345 $1.89 Million
Q3 2016

Dec 06, 2017
BUY
N/A
11,250 Added 34.78%
43,595 $2.35 Million
Q3 2016

Dec 04, 2017
BUY
N/A
32,345
32,345 $1.89 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email